Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Comment by MrMugsyon Mar 15, 2022 9:11pm
104 Views
Post# 34517125

RE:RE:RE:RE:RE:RE:Stifel brokerage location?

RE:RE:RE:RE:RE:RE:Stifel brokerage location?
porksniffer wrote: Everyone just SHUT UP and BE PATIENT. JRG told you this if for your grandkids! Who cares if every single shareholder who bought after the first day in 2014 is LOSING MONEY. Just shut up and wait, don't ask questions Shakira and JRG are on it!! Meir also warned you this is an empty shell of a company. Check back in 2039 when your grandkids are 25 years old... if you are not in a box 6 feet underground. 


Don't worry about the share price friend.
Worry about the growth.
Worry about the debt - oh - hardly have any.
The price always corrects itself - but - you will wait - even if you don't have shares.

: )


Knight Therapeutics

Year Revenue......Net Income

2014 365,000......125,859,000

2015 1,037,000.....34,167,000
2016 5,940,000.....18,560,000
2017 8,634,000.....17,244,000
2018 12,500,000....24,079,000
2019 47,461,000....18,033,000
2020 199,519,000...32,085,000

We know it took your friend Meir 10 years to get to $50,000,000 in annual sales. Unfortunately for him, he made the mistake of showing it to us when he was trying to oust Goodman.

How long do you think it took Meir to accumulate net income of of more than $200,000,000 ? He sure didn't do it in 6.5 years !!!!

Hahaha ! Love it !


<< Previous
Bullboard Posts
Next >>